Ascentage Pharma Group International (AAPG)

Heartland Financial USA Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-405.43	-925.64	-882.92	-782.42	-677.61
Depreciation & Amortization	91.07	90.81	60.92	27.53	26.49
Other Amortization	2.1	2.39	2	0.8	0.93
Loss (Gain) From Sale of Assets	-0.04	-0	-2.27	0.03	0
Loss (Gain) From Sale of Investments	0.83	0.7	9.77	20.89	3.75
Loss (Gain) on Equity Investments	0.28	-1.08	0.28	-	-
Stock-Based Compensation	20.92	31.5	22.11	46.97	74.03
Other Operating Activities	67.94	84.39	31.81	-108.13	10.19
Change in Accounts Receivable	62.75	-91.54	-0.39	-53.97	-
Change in Inventory	9.57	-6.72	-5.52	-3.93	-
Change in Accounts Payable	19.52	-23.11	24.7	47.5	10.28
Change in Unearned Revenue	4.09	82.98	-24.66	227.39	5.11
Change in Other Net Operating Assets	15.04	29.24	110.28	-17.01	-55.25
Operating Cash Flow	-111.36	-726.08	-653.92	-604.68	-609.96
Capital Expenditures	-24.29	-46.11	-203.29	-435.42	-249.92
Sale of Property, Plant & Equipment	-	0.01	2.35	0.34	-
Cash Acquisitions	-9.52	-20	-20	-20	-
Sale (Purchase) of Intangibles	-	-10.74	-33.68	-1.21	-1.56
Investment in Securities	-328.23	98.75	-130	-10.23	144.11
Investing Cash Flow	-362.04	21.92	-384.61	-466.52	-107.37
Long-Term Debt Issued	535.92	953.5	763.62	599.74	527.81
Long-Term Debt Repaid	-681.26	-966.86	-67.74	-60.24	-102.67
Net Debt Issued (Repaid)	-145.34	-13.36	695.87	539.5	425.14
Issuance of Common Stock	533.95	470.09	0.02	1,197	634.22
Repurchase of Common Stock	-	-5.92	-26.78	-25.87	-
Other Financing Activities	-73.84	-82.06	-49.85	70.97	-19.35
Financing Cash Flow	314.77	368.75	619.27	1,781	1,040
Foreign Exchange Rate Adjustments	13.68	27.81	58.01	-23.28	-41.69
Net Cash Flow	-144.95	-307.59	-361.25	686.91	280.99
Free Cash Flow	-135.65	-772.19	-857.2	-1,040	-859.88
Free Cash Flow Margin	-13.83%	-347.86%	-408.75%	-3726.60%	-6906.64%
Free Cash Flow Per Share	-0.45	-2.73	-3.25	-4.08	-3.98
Cash Interest Paid	60.56	92.35	49.85	16.81	5.94
Cash Income Tax Paid	-	-	-	3.85	-
Levered Free Cash Flow	-81.25	-706.12	-680.98	-954.65	-493.55
Unlevered Free Cash Flow	-40.96	-646.09	-647.99	-944.19	-489.65
Change in Working Capital	110.97	-9.15	104.41	189.65	-47.73

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q